Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Director's Dealing 2024

Nov 12, 2024

5292_dirs_2024-11-12_08ea0c4a-f033-451a-8cb5-3d405238c9f6.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 9575L

Centrica PLC

12 November 2024

Centrica plc (the 'Company')

12 November 2024

Notification of Transactions of Directors

The Company was notified by Equiniti Limited, the administrators of the Company's Share Incentive Plan (the 'Plan'), that Centrica plc ordinary shares of 6 14 /81 pence ('Shares') have been acquired under the Plan.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary shares of 6 14 /81  pence

GB00B033F229

b)

Nature of the transaction

Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by Equiniti Share Plan Trustees Limited under the Company's Share Incentive Plan

c)

Price(s) and volume(s)

Price(s) Volume(s)
£1.1685 128 (Partnership shares)
£1.15266666 22 (Matching shares)

d)

Aggregated information

Aggregated volume

-      Price

-      Total

150 Shares

£1.166 per Share

£174.93

e)

Date of the transaction

11 November 2024

f)

Place of the transaction

London Stock Exchange (Partnership shares)

Outside a trading venue (Matching shares)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russell O'Brien

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary shares of 6 14 /81 pence

GB00B033F229

b)

Nature of the transaction

Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by Equiniti Share Plan Trustees Limited under the Company's Share Incentive Plan

c)

Price(s) and volume(s)

Price(s) Volume(s)
£1.1685 129 (Partnership shares)
£1.15266666 22 (Matching shares)

d)

Aggregated information

Aggregated volume

-      Price

-      Total

151 Shares

£1.166 per Share

£176.10

e)

Date of the transaction

11 November 2024

f)

Place of the transaction

London Stock Exchange (Partnership shares)

Outside a trading venue (Matching shares)

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGPGAWGUPCGQP